Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Michele Senni et al.|New England Journal of Medicine|2021Cited by 4.6k
The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of CardiologyWilfried Müllens, Andrew J.S. Coats, Kevin Damman et al.|European Journal of Heart Failure|2019Cited by 1.1k
Organ Dysfunction, Injury and Failure in Acute Heart Failure: From Pathophysiology to Diagnosis and Management. A Review on Behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Veli‐Pekka Harjola, Alexandre Mebazaa, Wilfried Müllens et al.|European Journal of Heart Failure|2017Cited by 406
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart FailureAlberto Aimo, Michele Emdin, Giuseppe Vergaro et al.|JACC Heart Failure|2017Cited by 156
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, João Pedro Ferreira et al.|European Heart Journal|2020Cited by 143